Homegrown FMCG major Dabur India will exit categories such as tea, adult and baby diapers, and sanitising products as part of rationalisation of its underperforming products, said CEO Mohit Malhotra. The company, aiming "to achieve sustainable double-digit CAGR by FY28 in both topline and bottomline" has renewed its strategy focus, building on its core strengths, he added. Dabur is going for "rationalisation of underperforming products and SKUS in order to release capital for bigger bets. A few examples of these are Vedic tea, adult & baby diapers and Dabur Vita," said Malhotra during the investors' call. These segments contribute less than 1 per cent to Dabur's revenue, which stood at Rs 13,113.19 crore in FY25. "So we will get out of these categories and focus on big, bold equities which we have identified, and the core portfolio is where we will invest," said Malhotra. Dabur, as per its new vision strategy, would continue to invest in core brands, would focus on premiumisation
Dabur's stock fell as much as 4.36 per cent during the day to ₹461.1 per share, the biggest intraday loss since April 7 this year
The FMCG firm will phase out underperformers like Vedic Tea and Dabur Vita while investing in core and premium products to fuel long-term growth amid a weak demand climate
Despite a challenging operating environment, Dabur said it delivered 2.1 per cent constant currency revenue growth at ₹2,830 crore
Q4 FY25 company results today: 50 companies will post earnings reports for the January-March quarter on May 7
Dabur India manufactures the 'Real' brand of fruit juices in India, and uses the label of '100 per cent fruit juice' on its packaging
This comes at a time when the market is pushing for growth in urban areas, which has been impacted, while rural sales have been on an upward swing for the past few months
Dabur's stock fell as much as 7.57 per cent during the day to ₹458.2 per share, the worst intraday fall since October 2, 2024
Board has decided to approach new promoters, the Burman Group, for funds
Home-grown FMCG major Dabur has lowered the time of its strategic vision cycle from four years to three years aiming to create a more agile organisation amid a slowdown in the FMCG space and volatile geopolitical landscape. It has engaged consulting firm McKinsey & Co to refine and align its strategies for the next three years in line with the evolving dynamics, its CEO Mohit Malhotra said in an earnings call. "This exercise has already begun, and we plan to conclude the same by the end of the fiscal year. This will enable us to capture emerging opportunities and navigate the future with sharper and more focused vision," he said. Dabur has four-year vision plans and is currently in the seventh vision cycle. "Earlier we used to have a four-year vision cycle... We feel that in this volatile and heavy-headwind macroeconomic environment and FMCG not doing so well as a sector... we require a validation of our strategies through an external consultant," he said. Malhorta further said ..
FMCG major Dabur has become the second-largest player in the oral care segment in the modern trade channels, its chief executive officer Mohit Malhotra claimed on Monday. The company, which operates in the segment with Dabur Red Toothpaste and premium brand Meswak, ended the quarter with a 9.1 per cent growth and it believes that this segment has " huge potential". "The Gel toothpaste portfolio has received a good response, recording 50%+ y-o-y growth this quarter. Dabur oral care is now the 2nd brand in Modern Trade Pan-India," he said in the post-earnings call. "Even in modern trade, where the competitor is very strong with premium variants etc., there also we have become a number two brand now in modern trade. So, this is very encouraging for us," Malhotra added. The oral care market is led by Colgate Palmolive and FMCG major HUL is at the second spot with brands such as Pepsodent, Closeup and Ayush. "Dabur Red is doing well on the back of tailwind coming from the herbal catego
Homegrown FMCG major Dabur India Ltd on Thursday reported a 1.85 per cent increase in consolidated net profit to Rs 515.82 crore in the December quarter. The company had posted a net profit of Rs 506.44 crore in the year-ago period, Dabur India said in a regulatory filing. Its revenue from operations was up 3 per cent to Rs 3,355.25 crore during the quarter under review. It was Rs 3,255.06 crore in the corresponding quarter of the previous fiscal year. Dabur India's total expenses were at Rs 2,826.20 crore, up 3.9 per cent in the December quarter. Total income of Dabur, which includes other income, was at Rs 3,483.28 crore, up 3 per cent. Shares of Dabur India Ltd were trading at Rs 535.10 on the BSE after lunch session, up 3.27 per cent from the previous close.
Schezwan Chutney: Brand name or generic product? Delhi High Court is hearing arguments from Dabur India and Tata Consumer-owned Capital Foods
Technical chart shows that the Nifty Next 50 index looks weak and could slide towards 58,670 - implying an over 11% fall from present levels, whereas on the upside can jump by 6% to 70,200 levels.
Union Bank stock futures plunged nearly 8% on the back of 54% increase in OI. On the other hand, Dr. Lal Path Labs and Metropolis Health witnessed long build-up on Monday; shows derivatives data.
Hit by inflation, higher input costs and pricing measures, fast-moving consumer goods companies are expected to see a contraction in their gross margin and a modest-to-flat operating profit in the October-December quarter. Several FMCG makers are likely to log a low single-digit rise in their revenue, returning to the cycle of value-driven growth. One of the reasons could be that a number of companies have opted for a price hike in the December quarter due to rising costs of input items such as copra, vegetable oil, and palm oil. The price hikes came at a time when the urban market was dragged down by lowered consumption due to high food inflation. However, the rural market, which is slightly above one-third of the total FMCG market, stayed ahead of it. Some of the listed FMCG companies, such as Dabur and Marico, shared their updates for the third quarter of FY25, and analysts expect either flat or low single-digit volume growth. Home-grown firm Dabur expects a "low single-digit .
The maker of Hajmola candy and Real fruit juice said rural consumption continued to be resilient and grow faster than urban in the third quarter
The Religare open offer is priced at Rs 235 per share, amounting to Rs 2,116 crore
The RBI grants conditional approval for the Burman family's 26% stake offer in Religare, with restrictions on board changes. Sebi approval is still pending amid valuation disputes
As FMCG shares led by Godrej Consumer fell up to 11% on Monday post the volume growth concern; the Nifty FMCG index slipped below its 20-DMA after a two-week struggle; chart hints at further 4.5% dip.